Top News

The Nigerian Minister of Health and Social Welfare, Muhammad Pate, says that health systems in Nigerian will remain weak as long as developing countries like Nigeria continue to lose its trained health professionals to developed countries that did not invest in their first professional education. Pate made these remarks at the opening plenary of the 77th World Health Assembly (WHA) yesterday, saying half the world’s population is still facing “health poverty”, deprivations of access to affordable basic health care, such as immunisation, reproductive, maternal, newborn and child health care. 

Society for Family Health (SFH), has decried rising cases of abortion among married women in Nigeria, attributing the development to the rise in inflation and love for their families. The nonprofit, non-political, non-governmental organization which intervenes in various health fields, added that many married women undertake to abort pregnancies without the knowledge of their husbands.

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public notification on its website, 'Public Alert No.15/2023, regarding the recall of Caro White Skin Lightening Beauty Lotion by the European Union (EU) Rapid Alert System for Dangerous Non-Food Products (RAPEX). This action comes as the product fails to comply with the Cosmetic Products Regulation due to its high Kojic Acid concentration, surpassing the allowable maximum concentration of one percent. This conclusion was drawn by the EU Scientific Committee on Consumer Safety (SCCS).

The Phase II of the Human Papillomavirus (HPV) vaccination exercise will commence on 27th May, 2024 with Twenty-one states of the federation.

MeCure Industries, a pharmaceuticals company in Nigeria, has revealed it has secured approval from the National Agency for Food & Drug Administration and Control (NAFDAC) to launch production of the first locally manufactured alternative Amoxicillin-Clavulanic acid tablets, Amoxyclav 625mg. This was made known in a recent statement.“MeCure Industries completed its Beta-lactam plant (Amoxycillin and Clavulanic acid also known as Amoxyclav) and, in the first quarter of 2024, secured approval from NAFDAC to launch production of Amoxyclav 625mg tablets (the first locally manufactured alternative antibiotic tablets following the departure of major manufacturers of similar variants),” the statement said.

Scientists have created a vaccine that has the potential to protect against a broad range of coronaviruses, including varieties that are not yet known. The scientists from the University of Canbridge, the University of Oxford, and Caltech in the US are developing a novel approach called "proactive vaccinology" which aims to train the body's immune system to recognise several different coronaviruses. The vaccine is made by attaching harmless proteins from different coronaviruses to minuscule nanoparticles that are then injected to prime the body’s defences to fight the viruses should they ever invade. Because the vaccine trains the immune system to target proteins that are shared across many different types of coronavirus, the protection it induces is extremely broad, making it effective against known and unknown viruses in the same family.